Jun Yan
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 5
- Oncology top 10%
-
- Ferroptosis and cancer prognosis 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
-
- RNA modifications and cancer 8
- RNA Interference and Gene Delivery 4
-
- Nanoplatforms for cancer theranostics 7
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Immunology (2 papers)International Journal of Hyperthermia (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jun Yan
72 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 662
- Cancer Research 298
- Epidemiology 481
- Oncology 241
- Pulmonary and Respiratory Medicine 261
Countries citing papers authored by Jun Yan
This map shows the geographic impact of Jun Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yan more than expected).
Fields of papers citing papers by Jun Yan
This network shows the impact of papers produced by Jun Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yan. The network helps show where Jun Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 8 | |
| 12 | Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors | 2020 | 2 |
| 13 | Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma | 2020 | 1 |
| 14 | 2020 | 59 | |
| 15 | 2020 | 25 | |
| 16 | 2019 | 1 | |
| 17 | A Diverse Color-tunable Luminous Polyurethane Leather Coating Based on Long Persistent Phosphors and Photochromatic Spiropyrans | 2019 | 1 |
| 18 | 2017 | 7 | |
| 19 | 2016 | 36 | |
| 20 | A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomabreakdown → | 2012 | 551 |
About Jun Yan
Jun Yan is a scholar working on Medical Terminology, Hepatology, Cancer Research, Immunology and Epidemiology, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), RNA modifications and cancer (8 papers), Nanoplatforms for cancer theranostics (7 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Hepatology (662 citations), Cancer Research (298 citations), Epidemiology (481 citations), Oncology (241 citations) and Pulmonary and Respiratory Medicine (261 citations). Jun Yan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kuansheng Ma, Xiaowu Li, X Y Feng, Ping Bie, Shuguang Wang, Jiahong Dong, Kai Feng, Liusheng Wu, Jixian Liu and Xiaoqiang Li. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, International Journal of Hyperthermia, Chemical Engineering Journal and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.